期刊文献+

硼酸氧化锌冰片软膏维持治疗对局限性湿疹预后的影响 被引量:6

Prognosis of Localized Eczema after Maintenance Treatment with Compound Boric Acid and Zinc Oxide Ointments
下载PDF
导出
摘要 目的探讨外用硼酸氧化锌冰片软膏维持治疗对局限性湿疹复发情况的影响及其安全性。方法 230例局限性湿疹患者,外用糠酸莫米松乳膏治疗,达到临床痊愈的患者随机分两组,分别外用硼酸氧化锌冰片软膏(硼酸组)或尿素维E乳膏(润肤霜组)维持治疗,共2周。停药后观察8周,记录复发情况。结果 165例患者进入维持治疗,硼酸组83例,润肤霜组82例。停药8周后,硼酸组复发率20.48%,润肤霜组37.80%,差异有统计学意义(P<0.05)。硼酸组缓解时间(44.12±16.20)d长于润肤霜组(31.80±13.81)d,差异也有统计学意义(P<0.001)。维持治疗期间,硼酸组不良反应率为2.41%,润肤霜组未见不良反应。结论外用硼酸氧化锌冰片软膏维持治疗局限性湿疹有一定的延缓湿疹复发的作用,且安全性较好。 Objeetve To evaluate the efficacy and safety of compound boric acid and zinc oxide ointments for mainte- nance treatment of localized eczema. Methods Two hundreds and thirty patients cured from localized ecze- ma were randomly divided into compound boric acid group receiving compound boric acid and zinc oxide oint- ments, and emollient group receiving urea and vitamin E cream for 2 weeks. Recurrence rates were assessed 8 weeks after the discontinuation of treatment. Results One hundred and sixty-five patients, including 83 in compound boric acid group and 82 in emollient group, participated in this study. After without treatment for 8 weeks,the recurrence rates in the compound boric acid group and the emollient group were 20. 48% and 37. 80% , respectively ( P 〈 0.05 ). The remission time was longer in the compound boric acid than in emolli- ent group[ (44. 12± 16. 20) vs. (31.80 ± 13.81 ) days,P 〈0. 001 ) ]. The incidence of adverse reactions was 2.41% in the compound boric acid group during the maintenance treatment, and no adverse reactions were observed in the emollient group. Conclusion The maintenance treatment with compound boric acid and zinc oxide ointments can delay the recurrence of localized eczema and is safe.
出处 《中国皮肤性病学杂志》 CAS CSCD 北大核心 2015年第12期1251-1252,共2页 The Chinese Journal of Dermatovenereology
关键词 湿疹 维持治疗 硼酸氧化锌冰片软膏 尿素维E乳膏 Eczema Maintenance treatment Compound boric acid and zinc oxide ointments Urea and vitamin E cream
  • 相关文献

参考文献6

二级参考文献22

  • 1钟世红,古锐,王文.奇正青鹏膏治疗骨关节疼痛方解及有效成分介绍[J].西南军医,2007,9(1):88-90. 被引量:44
  • 2European Task Force on Atopic Dermatitis,Severity scoring of atopic dermatitis:the SCORAD index.Dermatology,1993,186(1):23-31.
  • 3Bwerh-Jones J,Damstra R,Golsch S,et al.Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis;randomised,double blind,parallel group study.BMJ,2003,326(7403):1367-1370.
  • 4Kirkup ME,Birchall NM,Weinberg EG,et al.Acute and maintenance treatment of atopic dermatitis in children-two comparative studies with fluticasone propionate (0.05%) cream.J Dermatolog Treat 2003,14(3):141-148.
  • 5Veien NK,Larsen PO,Thestrup-Pedersen K,et al.Long-term,intermittent treatment of chronic hand eczema with mometasone furoate.Br J Dermatol,1999,140(5):882-886.
  • 6Moller H,Svartholm H,Dahl G.Intermittent maintenance therapy in chronic hand eczema with clobetasol propionate and flupredniden acetate.Curr Med Res Opin,1983,8(9):640-644.
  • 7Hanifin J,Gupta AK,Rajagopalan R,Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients.Br J Dermatol,2002,147(3):528-537.
  • 8Li LF, Liu G, Wang J. Prognosis of unclassified eczema: a follow-up study. Arch Dermatol, 2008, 144(2): 160-164.
  • 9Veien NK, Hattel T, Laurberg G. Hand eczema: causes, course, and prognosis Ⅱ. Contact Dermatitis, 2008, 58(6): 335-339.
  • 10张建中主译.皮肤病治疗学最新循证治疗策略.3版.北京:人民卫生出版社,2011:25.

共引文献47

同被引文献81

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部